Krsnaa Diagnostics Limited conducted its 16th Annual General Meeting on September 28, 2026. Shareholders considered resolutions including the adoption of financial statements and a final dividend declaration.
Krsnaa Diagnostics Ltd reported the successful passing of a special resolution via postal ballot approving the issuance of up to 16,21,000 convertible warrants to promoters.
Krsnaa Diagnostics Limited has submitted the notice of its 16th Annual General Meeting, scheduled for September 28, 2026, along with the Annual Report for 2025-26.
Krsnaa Diagnostics issued a corrigendum to its Postal Ballot notice, providing additional disclosures regarding the proposed preferential issue of share warrants to promoters.
Krsnaa Diagnostics disclosed voting results for its postal ballot. Resolutions for re-appointing and appointing independent directors were passed with requisite majority.
Krsnaa Diagnostics Limited issued a postal ballot notice for director re-appointments and commission approvals. Shareholders can vote electronically from June 5 to July 4, 2026.
Krsnaa Diagnostics Ltd announced the approval of Mr. Rajendra Khivraj Mutha's re-appointment as Executive Chairman for five years via postal ballot. The ordinary resolution was passed with a 99.99% majority on April 16, 2026. The remote e-voting results and scrutinizer's report have been submitted to the exchanges.